Trial intelligence / Profile preview

The effect of GLP-1 in psoriasis

2011-000571-13Phase 4Completed

Sponsor
Gentofte Hospital
Start
Apr 2011
Modality
Peptides
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in psoriasis comparing Victoza with Placebo (2 arms). Primary endpoint: PASI (psoriasis area and severity index). Started Apr 2011; status: completed.

02

Drugs

03

Conditions

psoriasis

Beyond the preview

Go deeper on 2011-000571-13.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-000571-13.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call